We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stericycle (SRCL) Q1 Earnings to Reflect SQ Pricing Pressure
Read MoreHide Full Article
Stericycle, Inc. (SRCL - Free Report) is slated to report first-quarter 2019 results on May 2, after the bell. In the last reported quarter, the company delivered positive earnings surprise of 7.3%.
Shares of the company have gained 58.6% year to date, significantly outperforming the 19.9% rally of the industry it belongs to.
How things are shaping up for the announcement
The Zacks Consensus Estimate for revenues in the to-be-reported quarter is pegged at $866 million, indicating a decline of 3.2% from the year-ago quarter reported figure. The decline is likely to be due to deterioration in small-quantity medical waste business combined with continued softness in Communication and Related Services, and divestitures. Strength in Secure Information Destruction and other core services is expected to partially offset the downside.
Moreover, weakness in Communication and Related Services and SQ (small quantity) pricing pressure are likely to hurt the bottom line. The Zacks Consensus Estimate for earnings is pegged at 87 cents, implying decline of 28% from the year-ago period reported figure.
What Our Model Says
According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. Zacks Rank #4 (Sell) or 5 (Strong Sell) stocks are best avoided, especially when the company is seeing negative estimate revisions. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.
Stericycle has an Earnings ESP of -8.73% and a Zacks Rank #4.
Here are a few stocks from the broader Zacks Business Services sector that investors may consider as our model shows that these have the right combination of elements to beat on earnings in first-quarter 2019:
FLEETCOR Technologies has an Earnings ESP of +0.38% and a Zacks Rank #2. The company is scheduled to report results on May 7.
EVERTEC (EVTC - Free Report) has an Earnings ESP of +3.73% and a Zacks Rank #3. The company is slated to release results on May 1.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Image: Bigstock
Stericycle (SRCL) Q1 Earnings to Reflect SQ Pricing Pressure
Stericycle, Inc. (SRCL - Free Report) is slated to report first-quarter 2019 results on May 2, after the bell. In the last reported quarter, the company delivered positive earnings surprise of 7.3%.
Shares of the company have gained 58.6% year to date, significantly outperforming the 19.9% rally of the industry it belongs to.
How things are shaping up for the announcement
The Zacks Consensus Estimate for revenues in the to-be-reported quarter is pegged at $866 million, indicating a decline of 3.2% from the year-ago quarter reported figure. The decline is likely to be due to deterioration in small-quantity medical waste business combined with continued softness in Communication and Related Services, and divestitures. Strength in Secure Information Destruction and other core services is expected to partially offset the downside.
Moreover, weakness in Communication and Related Services and SQ (small quantity) pricing pressure are likely to hurt the bottom line. The Zacks Consensus Estimate for earnings is pegged at 87 cents, implying decline of 28% from the year-ago period reported figure.
What Our Model Says
According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. Zacks Rank #4 (Sell) or 5 (Strong Sell) stocks are best avoided, especially when the company is seeing negative estimate revisions. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.
Stericycle has an Earnings ESP of -8.73% and a Zacks Rank #4.
Stericycle, Inc. Price and EPS Surprise
Stericycle, Inc. Price and EPS Surprise | Stericycle, Inc. Quote
Stocks That Warrant a Look
Here are a few stocks from the broader Zacks Business Services sector that investors may consider as our model shows that these have the right combination of elements to beat on earnings in first-quarter 2019:
WEX (WEX - Free Report) has an Earnings ESP of +1.78% and a Zacks Rank #2. The company is scheduled to report results on May 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
FLEETCOR Technologies has an Earnings ESP of +0.38% and a Zacks Rank #2. The company is scheduled to report results on May 7.
EVERTEC (EVTC - Free Report) has an Earnings ESP of +3.73% and a Zacks Rank #3. The company is slated to release results on May 1.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Click to get it free >>